A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

NCT01993433 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: DRM02
OTHER: Vehicle

Sponsor

Dermira, Inc.